Stock Market Today: Disney Earnings Keep Dow, S&P Afloat
Impressive quarterly results from Disney helped offset a sharp drop in consumer confidence.
Stocks were choppy in today's low-volume session, as investors balanced another strong round of earnings against a dismal reading on consumer confidence.
In terms of earnings, Walt Disney (DIS, +1.0%) gained the bulk of headlines after reporting a fiscal third quarter with much higher-than-expected earnings, revenues and Disney+ subscriber numbers.
"The streaming story for Disney remains intact," says Carter Henderson, portfolio specialist and director of institutional development at Fort Pitt Capital Group. Results from Disney's parks and entertainment segment were strong, too, achieving "positive profits when many analysts didn't expect profitability to return until later in 2021 or even next year," per Henderson.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
But this good news was tempered by data from the University of Michigan, which showed consumer confidence plunged to 70.2 in August – its lowest reading since April 2020 – with those surveyed expressing concern over unemployment, inflation and the quickly spreading delta variant.
Still, the Dow Jones Industrial Average (+0.04% to 35,515) and S&P 500 Index (0.2% to 4,468) managed to end the week at new highs.
Other news in the stock market today:
- The Nasdaq Composite eked out a 0.04% gain to 14,822.
- Several pharmaceutical stocks moved higher today, after the Food and Drug Administration authorized COVID-19 vaccine booster shots in immunocompromised individuals, including those with HIV and cancer. Among the names getting a lift were Pfizer (PFE, +2.6%), BioNTech (BNTX, +0.9%) and Johnson & Johnson (JNJ, +0.5%).
- Food delivery firm DoorDash (DASH, +3.5%) gained ground in the wake of its second-quarter earnings report. DASH said gross order volume surged 70% from the year prior to $10.5 billion, while revenue jumped 83% to $1.2 billion and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). While these figures were higher than analysts were expecting, DASH did say in its shareholder letter that it "anticipates a seasonal decline in new consumer acquisition and order rates in Q3."
- U.S. crude oil futures slipped 0.9% to settle at $68.44 per barrel.
- Gold futures gained 1.5% to finish at $1,778.20 an ounce.
- The CBOE Volatility Index (VIX) retreated 0.9% to 15.45.
- Bitcoin rose 4.6% to $46,476.13. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m. each trading day.)
Don't Sweat the Small-Cap Underperformance
In the back of the pack today were small caps, with the Russell 2000 slipping 0.9% to 2,223. This is nothing new, with small caps lagging their larger-cap brethren dramatically over the past six months.
Scott Wren, senior global market strategist at Wells Fargo Investment Institute, says it's nothing to fear, and this underperformance is likely due to the "market getting concerned that future growth expectations are not going to pan out" as a result of a resurgence in COVID-19 cases.
"From our view, this small-cap underperformance is a temporary stumble," Wren adds.
For those investors who share this view that small caps will eventually bounce, we've recently compiled a list of the best small-cap stocks to buy, according to the pros.
And for those who want to add a little oomph to their portfolios, may we suggest these small-cap dividend stocks. While not typically known as income-building investments, this list of names offer hefty payouts for shareholders.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at a local investment research firm. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Snowbirds: Avoid These 3 Sneaky Insurance IssuesBefore snowbirds depart for their winter retreat, they should check their insurance coverage for surprises that might arise, or else be on the hook for repairs.
-
Hang in There With This Value FundPatience is required for investors in the Dodge & Cox Stock Fund, but its long-term outperformance proves it's worth the wait.
-
Dow Dives 797 Points as Government Opens: Stock Market TodayThe process of pricing and re-pricing realities old and new never stops, and next week promises to be at least as exciting as this week.
-
Risk Is Off Again, Dow Falls 397 Points: Stock Market TodayMarket participants are weighing still-solid earnings against both expectations and an increasingly opaque economic picture.
-
If You'd Put $1,000 Into Home Depot Stock 20 Years Ago, Here's What You'd Have TodayHome Depot stock has been a buy-and-hold banger for truly long-term investors.
-
S&P 500 Sees New Highs on Shutdown Day: Stock Market TodayMost of its components were in the red, but the S&P 500 Index still managed to hit a new intraday all-time high.
-
If You'd Put $1,000 Into Bank of America Stock 20 Years Ago, Here's What You'd Have TodayBank of America stock has been a massive buy-and-hold bust.
-

If You'd Put $1,000 Into Oracle Stock 20 Years Ago, Here's What You'd Have TodayORCL Oracle stock has been an outstanding buy-and-hold bet for decades.
-
How to Invest for Rising Data Integrity RiskAmid a broad assault on venerable institutions, President Trump has targeted agencies responsible for data critical to markets. How should investors respond?
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.